Related Experiment Video
Updated: Jun 12, 2026
10:39
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Tolerizing allergic responses in the lung
1Leukocyte Biology Section, National Heart and Lung Institute, Faculty of Medicine, Imperial College, London, UK. c.lloyd@imperial.ac.uk
Mucosal Immunology
|May 28, 2010
Summary
The pulmonary immune system balances responses to pathogens and allergens. Understanding immune tolerance breakdown in asthma may lead to new therapies for allergic diseases.
Area of Science:
- Immunology
- Pulmonary Medicine
- Allergy Research
Background:
- The pulmonary immune system must control infections while tolerating harmless inhaled substances.
- Lung stromal cells and immune cells form a network to maintain this tolerance.
- A breakdown in tolerance leads to allergic diseases like asthma.
Purpose of the Study:
- To explore the mechanisms of immune tolerance in the lungs.
- To understand factors contributing to the loss of tolerance in allergic individuals.
- To identify potential therapeutic targets for chronic asthma.
Main Methods:
- This study reviews current understanding of pulmonary immune responses.
- It examines the interplay between genetic and environmental factors in allergy development.
- The research synthesizes evidence on immune tolerance mechanisms.
Main Results:
- Immune tolerance is crucial for preventing inflammatory responses to allergens.
- Genetic predisposition and early environmental exposures, like pathogens, influence tolerance.
- Dysregulation of immune tolerance contributes to allergic pathology.
Conclusions:
- Further research into pulmonary immune tolerance mechanisms is needed.
- Understanding these mechanisms could reveal novel therapeutic strategies for asthma.
- Targeting immune tolerance pathways may offer new treatments for allergic respiratory diseases.
Related Concept Videos
02:06Allergic Reactions
Overview
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:27Allergic Drug Reactions
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...